AzTrials
AzTrials

Posttraumatic Stress DisorderNCT02737098

TOP Implementation Project

A study testing Enhanced Implementation Strategy and Standard Implementation Strategy in people with Posttraumatic Stress Disorder, run by VA Office of Research and Development at 6 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Veterans Health Administration (VHA) provides care to 3.3 million Veterans living in rural areas, comprising 36% of all VHA enrollees. In 1995, VHA began expanding its system of Community Based Outpatient Clinics (CBOCs) in order to improve access for the geographically dispersed Veteran population. Read more about this study

Who is it for?
Ages 18 to 99 years
Conditions the study is for
Posttraumatic Stress Disorder
What is being tested?
Enhanced Implementation Strategy and Standard Implementation Strategy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
544 participants
Where
6 sitesUnited States
Study dates
1 Apr 2016to 30 Sep 2020
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • PTSD Diagnosis
  • Positive PTSD Screen

Who cannot join

  • No specialty mental health encounters at the VAMC

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

United States6 sites
  • Ralph H. Johnson VA Medical Center, Charleston, SC

    Charleston, South Carolina, 29401-5799

  • VA Eastern Colorado Health Care System, Denver, CO

    Denver, Colorado, 80220

  • Iowa City VA Health Care System, Iowa City, IA

    Iowa City, Iowa, 52246-2208

  • Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR

    Little Rock, Arkansas, 72205-5484

  • VA San Diego Healthcare System, San Diego, CA

    San Diego, California, 92161

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA

    Seattle, Washington, 98108

Other trials in United States

About this study

Official title: Implementation of Telemedicine Outreach for PTSD (TOP) in Small Rural CBOCs (QUE 15-282)

The Veterans Health Administration (VHA) provides care to 3.3 million Veterans living in rural areas, comprising 36% of all VHA enrollees. In 1995, VHA began expanding its system of Community Based Outpatient Clinics (CBOCs) in order to improve access for the geographically dispersed Veteran population. There are now approximately 900 CBOCs delivering a range of services to approximately 64% of VHA enrollees. While these CBOCs have dramatically improved access to first class primary care services, it has been more challenging to deliver specialty mental health care to rural Veterans. Evidence based specialty mental care practices developed for large VA Medical Centers are often not feasible to deploy in small CBOCs and thus not accessible to rural Veterans. Telemedicine Outreach for PTSD (TOP) is a technology-facilitated virtual care clinical intervention that is designed to enhance access to evidence based psychotherapy and pharmacotherapy for posttraumatic stress disorder (PTSD). The TOP clinical intervention is delivered by a virtual care team comprising a CBOC provider, and a telephone care manager, telepsychologist and telepsychiatrist located at the VAMC.

The goal of this implementation project is to support the national deployment of the TOP intervention and evaluate its clinical effectiveness in routine care. The specific aims are to compare the effectiveness of alternative implementation strategies to promote uptake of TOP and assess impact on access and PTSD outcomes. The standard VA implementation strategy will follow standard procedures for deploy clinical practices in the VA include disseminating support materials, providing technical assistance and transfer funds to hire clinical personnel. The enhanced implementation strategy will add external facilitation to the standard VA implementation strategies.

The project will compare the standard VA implementation strategy to the enhanced implementation strategy. All VAMCs will receive the enhanced implementation strategy if they need it, but the time period during which they will receive the enhanced implementation strategy will be randomized. This will allow us to determine whether more patients are reached by the TOP intervention during standard implementation compared to enhanced implementation. Data will be collected from patient survey and chart review for all patients sampled for the evaluation. Participating patients will complete a baseline survey and 3 follow-up surveys. The reach implementation outcome measure will be specified as the proportion of sampled patients who received the TOP intervention. PTSD outcomes will be specified as a continuous change in patient self-reported symptom severity between baseline and follow-up. Perceived access will be measured using items specifically developed for the project.

Read the detailed description

Background

The Veterans Health Administration (VHA) provides care to 3.3 million Veterans living in rural areas, comprising 36% of all VHA enrollees. In 1995, VHA began expanding its system of Community Based Outpatient Clinics (CBOCs) in order to improve access for the geographically dispersed Veteran population. There are now approximately 900 CBOCs delivering a range of services to approximately 64% of VHA enrollees. While these CBOCs have dramatically improved access to first class primary care services, it has been more challenging to deliver specialty mental health care to rural Veterans. Evidence based specialty mental care practices developed for large VA Medical Centers are often not feasible to deploy in small CBOCs and thus not accessible to rural Veterans. Rural Veterans with posttraumatic stress disorder (PTSD) treated at CBOCs experience little to no improvement in their symptoms over time. A major contributor of poor PTSD outcomes is that trauma-focused evidence-based psychotherapy is not being provided to Veterans in the CBOC setting. Moreover, travel barriers prevent most rural Veterans from receiving trauma-focused evidence-based psychotherapy at large VHA Medical Centers (VAMC). Telemedicine Outreach for PTSD (TOP) is a technology-facilitated virtual care clinical intervention that is designed to enhance access to evidence based psychotherapy and pharmacotherapy.

Specific Aims Impact Goal - The goal of this proposed Type III Hybrid effectiveness-implementation project is to support the national deployment of the TOP intervention and evaluate its clinical effectiveness in routine care.

Specific Aim 1 - Compare the effectiveness of a standard VA implementation strategy to an enhanced implementation strategy in promoting uptake of TOP.

Hypothesis 1 - For sites not implementing TOP performance metric benchmark with a standard implementation strategy, those randomized to the enhanced implementation strategy will have better reach and engagement outcomes than those randomized to continued standard VA implementation. Reach is defined using two variables: 1) the likelihood of having a care manager encounter and 2) the likelihood of having an evidence based psychotherapy encounter.

Specific Aim 2 - Determine if implementation of TOP in routine care improves PTSD outcomes for rural Veterans.

Hypothesis 2 -For sites not implementing TOP performance metric benchmark with a standard implementation strategy, those randomized to the enhanced implementation strategy will have better perceived access and PTSD outcomes than those randomized to continued standard VA implementation.

Methodological Approach

Setting - The project will be conducted at 6 VAMCs. CBOCs served by these 6 VAMCs without on-site psychologists trained in trauma-focused evidence-based psychotherapy will be identified and a CBOC or combination of CBOCs with 300-400 eligible patients will be selected as the implementation site(s).

Population (for evaluation) - Using administrative data from VHA's Clinical Data Warehouse (CDW), the investigators will identify all patients at participating CBOCs whose most recent PC-PTSD screen was positive, had a VHA encounter in the past 12 months with a PTSD diagnosis, and had no specialty mental health encounters at the VAMC in the past 6 months. Eligible patients will be sampled for the evaluation from the selected CBOCs and 100 will be recruited to participate from each VAMC via opt-out letters. The total anticipated sample size will be 600. Participating patients will complete a baseline survey and 3 follow-up surveys every 9 months. Local clinicians at implementation sites will have the flexibility to decide who is eligible to receive the TOP clinical intervention, but the investigators expect there will be considerable overlap between those who are eligible for the evaluation and those considered to be eligible for the TOP intervention by local clinicians.

Telemedicine Outreach for PTSD (TOP) Intervention - TOP is delivered by a virtual care team comprising a CBOC provider, and a telephone care manager, telepsychologist and telepsychiatrist located at the VAMC. The telephone care manager activities include: education, activation, barrier assessment/resolution, medication adherence and side-effect monitoring, therapy/homework adherence monitoring and symptom monitoring. The telepsychologist activities include the delivery of trauma-focused evidence-based therapy (e.g., Cognitive Processing Therapy [CPT] or Prolonged Exposure Therapy [PE]). The telepsychiatrist activities include conducting case reviews and psychiatric consultations. The core element of the TOP intervention is a case review by the virtual care team (telephone care manager, telepsychologist and telepsychiatrist) of all patients newly enrolled in care management and all those not responding to treatment, along with documentation of the case review in the Electronic Health Record. Given the dynamic nature of technology and the high degree of variability in context across clinics, the investigators will employ methods that enable the new clinical intervention to be adapted from setting to setting and to be refined over time rather than focusing on fidelity to a manualized protocol. The telepsychiatry and telepsychology can either be delivered via interactive video to the CBOC or via clinical video telehealth to home. The Veteran and the telepsychologist can choose to use smartphone apps (CPT Coach or PE Coach) designed to augment these two trauma-focused evidence-based therapies. Care managers can also use secure messaging with patients in addition to telephone calls.

Standard VA Implementation Strategy - Standard VA implementation strategies will include disseminating a TOP clinical intervention manual, a TOP local champion guide, care manager training materials, PTSD case-finder tool (with the same inclusion/exclusion criteria used for evaluation sample), and technical support from the facility level telehealth technician. Internal facilitation will be conducted by the designated local champion. In addition, each VAMC will receive funds from the Office of Rural Health to hire a full time telephone care manager for three years devoted to managing CBOC patients with mental health disorders including PTSD.

Enhanced VA Implementation Strategy - The enhanced implementation strategy will add external facilitation to the standard VA implementation strategies. External facilitation will begin with an assessment of the current workflow at the VHA Medical Center and the affiliated CBOCs using System Redesign methods. A member of the external facilitation team will conduct site visits at each VAMC and conduct telephone interviews with CBOC staff. The member of the external facilitation team will also collaborate with the local System Redesign staff member. To assess clinical workflow, the investigators will examine the administrative structure of the clinical units, staffing patterns, scopes of practice, service mix, standard operating procedures (e.g., patient check-in, screening, referrals, coding), job descriptions and annual evaluation criteria, and use of technology including telehealth, eHealth, mHealth, and the electronic health record. For the TOP intervention, key clinical workflow elements include: 1) how patients are referred to the care managers, 2) whether care managers are located at the VISN, VAMC or CBOC and in what administrative unit they are housed, 3) what type of psychotherapy is provided at the CBOC (e.g., anger management, PTSD groups, etc.), 4) formulary restrictions and prescribing patterns, 5) how psychiatric consultations are arranged, 6) how frequently patients are seen in mental health and primary care, caseloads, and wait times, 7) appointment scheduling procedures for mental health and primary care, 8) no show rates, 9) care manager software availability, 10) use of interactive video, clinical video telehealth to home, SmartPhone apps, 10) use of psychiatric rating scales, and 11) how workload credit is distributed. The external facilitation team will then generate a clinical workflow chart that describes the current process of care. With advice from the external facilitation team, the local champion will then incorporate the clinical process of the TOP intervention (including use of technology) into the current clinical workflow chart, making changes to the TOP intervention and/or current clinical workflow as needed. The local champion will also meet monthly with external facilitators to troubleshoot and make refinements.

Project Design - A stepped wedge design will be used for this Type III Hybrid Effectiveness-Implementation project. The project will compare implementation outcomes (patient access, reach, and symptoms) of the standard VA implementation strategy to the implementation outcomes of the enhanced implementation strategy. The investigators will begin by collecting pre-implementation access and symptom data from a sample of patients. In the first implementation step, all six VAMCs will conduct the standard VA implementation strategy at the selected CBOCs for nine months. At the end of the first implementation step, will collect follow-up data from the sample of patients to assess perceived access, intervention reach, and clinical effectiveness. A performance measure benchmark will be used to determine whether the standard implementation effort is successful in the first implementation step. The investigators will define implementation success based on the capacity of the full-time care manager to enroll a prespecified number of patients. Specifically, the care manager will report the number of patients enrolled in the care management protocol to the evaluation team and implementation success will be defined as 75 enrolled patients over the 9-month period and 35% of those initiated an evidence-based psychotherapy for PTSD. If this performance measure benchmark is attained, the VAMC will continue the standard VA implementation efforts, and the investigators will continue to collect evaluation data. If the performance measure benchmark is not attained, the VAMC will be randomized to either continued standard VA implementation strategy or the enhanced implementation strategy in the next step. In the second implementation step, these VAMCs will conduct either the standard or enhanced implementation strategy at selected CBOCs for nine months. At the end of the second implementation step, the investigators will again collect follow-up data from the sample of patients to assess perceived access, intervention reach, and clinical effectiveness. If the performance measure benchmark is attained in the second step at standard or enhanced implementation sites, the VAMC will continue standard implementation efforts. If the performance measure benchmark is not attained at standard implementation sites, the VAMC will receive the enhanced implementation strategy in the next step. If the performance measure benchmark is not attained at enhanced implementation sites, the VAMC will continue to receive enhanced implementation. At the end of the third implementation step, the investigators will again collect follow-up data from the sample of patients to assess perceived access, intervention reach, and clinical effectiveness.

Outcome Measures - The evaluation of the implementation strategies will be based on the RE-AIM framework. Data will be collected from patient survey and chart review for all patients sampled for the evaluation. The reach implementation outcome measure will be specified as the proportion of sampled patients who received the core element of the TOP intervention (having a care manager encounter). This will be assessed by chart review at three time points: 1) 9 month follow-up, 2) 20 month follow-up, and 3) 31 month follow-up. For each patient sampled, perceived access and clinical effectiveness data will be collected at four different time points: 1) pre-implementation baseline, 2) 9 month follow-up, 3) 20 month follow-up, and 4) 31 month follow-up. PTSD outcomes will be specified as a continuous change in the PCL-5 score between baseline and follow-up. Perceived access will be measured using items specifically developed for the project.

Data Analysis - The stepped wedge design allows us to estimate the effectiveness of the implementation strategy by comparing outcomes between groups of VAMCs randomized to standard or enhanced implementation and by comparing outcomes over time within the same VAMC as it is transitioned from standard implementation to enhanced implementation. Following intent to treat principals, the investigators will estimate the clinical effectiveness of TOP for the entire sample regardless of whether they were reached to generate a measure of population level effectiveness. Generalized linear models will be used to account for the clustering of patients and providers within VAMCs and CBOCs. VAMCs and CBOCs will specified as random effects and time period will be specified as a fixed effect. The reach, access and PTSD outcome regressions will be estimated using patients as the unit of analysis and data from all VAMCs will be included regardless of whether the VAMC attained the performance measure benchmark. To test hypotheses, the explanatory variable will be whether the VAMC was randomized to standard VA implementation or enhanced implementation during each step.

Being tested
Enhanced Implementation Strategy, Standard Implementation Strategy
Keywords
PTSD, virtual care, implementation, telepsychiatry, telepsychology
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Enhanced Implementation StrategyOther

    The enhanced implementation strategy will add external facilitation to the standard VA implementation strategies. External facilitation will begin with an assessment of the current workflow at the VHA Medical Center and the affiliated CBOCs using System Redesign methods. The external facilitation team will then generate a clinical workflow chart that describes the current process of care. With advice from the external facilitation team, the local champion will then incorporate the clinical process of the TOP intervention into the current clinical workflow chart, making changes to the TOP intervention and/or current clinical workflow as needed. The local champion will also meet monthly with external facilitators to troubleshoot and make refinements.

  • Standard Implementation StrategyOther

    Standard VA implementation strategies will include disseminating a clinical intervention manual, a local champion guide, care manager training materials, PTSD case-finder tool, and technical support from the facility level telehealth technician. Internal facilitation will be conducted by the designated local champion. In addition, each VAMC will receive funds to hire a full time telephone care manager.

Study groups in NCT02737098
Study groupRoleWhat they receive
Standard ImplementationActive comparatorStandard VA implementation strategies will include disseminating a clinical intervention manual, a local champion guide, care manager training materials, PTSD case-finder tool, and technical support from the facility level telehealth technician. Internal facilitation will be conducted by the designated local champion. In addition, each VAMC will receive funds to hire a full time telephone care manager.
Receives: Other: Standard Implementation Strategy
Enhanced Implementation StrategyActive comparatorThe enhanced implementation strategy will add external facilitation to the standard VA implementation strategies. External facilitation will begin with an assessment of the current workflow at the VHA Medical Center and the affiliated CBOCs using System Redesign methods. The external facilitation team will then generate a clinical workflow chart that describes the current process of care. With advice from the external facilitation team, the local champion will then incorporate the clinical process of the TOP intervention into the current clinical workflow chart, making changes to the TOP intervention and/or current clinical workflow as needed. The local champion will also meet monthly with external facilitators to troubleshoot and make refinements.
Receives: Other: Enhanced Implementation Strategy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reach: the Proportion of Sampled Patients Who Received the Core Element of the TOP Intervention

    The reach implementation outcome measure will be specified as the proportion of sampled patients who received the core element of the TOP intervention (documentation in the electronic health record of a care manager encounter).

    Measured: 31 months (Step 1 - 9 months; Gap 1 - 2 months; Step 2 - 9 months; Gap 2 - 2 months; Step 3 - 9 months)

Secondary outcomes (4)
  1. PTSD Symptom Severity

    PTSD symptom severity will be measured using the PTSD Check List (version 5). The outcome will be the average change score on this scale (from baseline to follow-up). Minimum=0; Maximum=80; higher scores indicate worse outcomes.

    Measured: 31 months (Step 1 - 9 months; Gap 1 - 2 months; Step 2 - 9 months; Gap 2 - 2 months; Step 3 - 9 months)

  2. Perceived Travel Burden: Degree to Which Sampled Patients Report That Traveling Interferes With Getting Services.

    How much does having to travel to VA appointments interfere with getting the PTSD services you want? Would you say it? Completely interferes, Interferes a great deal, Interferes somewhat, Interferes a little bit, Does not interfere at all. The outcome will be the proportion responding that it completely interferes or interferes a great deal.

    Measured: 31 months (Step 1 - 9 months; Gap 1 - 2 months; Step 2 - 9 months; Gap 2 - 2 months; Step 3 - 9 months)

  3. Perceived Wait Time: Degree to Which Sampled Patients Report That Appointment Wait Time Interferes With Getting Services.

    How much does having to wait for VA appointments interfere with getting the PTSD services you want? Would you say it? Completely interferes, Interferes a great deal, Interferes somewhat, Interferes a little bit, Does not interfere at all. The outcome will be the proportion responding that it completely interferes or interferes a great deal.

    Measured: 31 months (Step 1 - 9 months; Gap 1 - 2 months; Step 2 - 9 months; Gap 2 - 2 months; Step 3 - 9 months)

  4. Perceived Trust: Degree to Which Sampled Patients Report That Lack of Trust in Providers Interferes With Getting Services.

    How much does lack of trust in VA providers interfere with getting the PTSD services you want? Would you say it? Completely interferes, Interferes a great deal, Interferes somewhat, Interferes a little bit, Does not interfere at all. The outcome will be the proportion responding that it completely interferes or interferes a great deal.

    Measured: 31 months (Step 1 - 9 months; Gap 1 - 2 months; Step 2 - 9 months; Gap 2 - 2 months; Step 3 - 9 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2016 (estimated)
  2. Study start1 Apr 2016
  3. Primary completion31 Jul 2019
  4. Study completion30 Sep 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
544 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02737098
Sponsor's protocol ID
QUX 16-005
Other IDs
QUE 15-282
Status last verified
Apr 2026
First submitted
21 Mar 2016
Last updated
1 May 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fortney JC, Rajan S, Chen JA, Campbell SB, Nolan JP, Wong E, Sayre G, Petrova V, Simons CE, Reisinger HS, Schnurr PP. A mixed-methods evaluation of why an implementation trial failed to engage veterans with posttraumatic stress disorder in trauma-focused psychotherapy. J Trauma Stress. 2023 Aug;36(4):762-771. doi: 10.1002/jts.22946. Epub 2023 Jun 27.

    PubMed 37370238
  • Fortney JC, Rajan S, Reisinger HS, Moeckli J, Nolan JP, Wong ES, Rise P, Petrova VV, Sayre GG, Pyne JM, Grubaugh A, Simsek-Duran F, Grubbs KM, Morland LA, Felker B, Schnurr PP. Deploying a telemedicine collaborative care intervention for posttraumatic stress disorder in the U.S. Department of Veterans Affairs: A stepped wedge evaluation of an adaptive implementation strategy. Gen Hosp Psychiatry. 2022 Jul-Aug;77:109-117. doi: 10.1016/j.genhosppsych.2022.03.009. Epub 2022 Mar 26.

    PubMed 35596963

Questions about this trial

What is this clinical trial studying?

A study testing Enhanced Implementation Strategy and Standard Implementation Strategy in people with Posttraumatic Stress Disorder, run by VA Office of Research and Development at 6 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 1 May 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reach: the Proportion of Sampled Patients Who Received the Core Element of the TOP Intervention (time frame: 31 months (Step 1 - 9 months; Gap 1 - 2 months; Step 2 - 9 months; Gap 2 - 2 months; Step 3 - 9 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02737098, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in